Treating skin cancers with surgery is still the standard of care for most NMSC patients. However, surgery is not without potential downsides, especially for patients with other health issues. Surface radiotherapy, both Electronic Brachytherapy (EBT) and Superficial Radiation Therapy (SRT), is an FDA-approved treatment option and an excellent choice for select NMSC patients. Explore the case study below to see how Dr. Steven Davis has had success treating patients with surface radiation therapy.
Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at AAPM 2024
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 66th Annual Meeting & Exhibition of the American Association of Physicists in Medicine (AAPM) in Los Angeles, CA, from July 21-25, 2024, at booth 518.